Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats

World Journal of Gastroenterology

Volumn 20, Issue 7, 2014, Pages 1822-1832

  Qian, Hui ^a,b   Shi, Jian ^a   Fan, Ting Ting ^a   Lv, Jiao ^b   Chen, Si Wen ^a   Song, Chun Yan ^a   Zheng, Zhi Wu ^b   Xie, Wei Fen ^a   Chen, Yue Xiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b No 411 Hospital of PLA   (China)

Author keywords

Cytokines; Hepatic stellate cells; Liver fibrosis; Sophocarpine; Toll like receptor 4

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROXYPROLINE; I KAPPA B KINASE INHIBITOR; INTERLEUKIN 6; MATRINE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN; PLACEBO; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; ALKALOID; COLLAGEN; COLORING AGENT; DIMETHYLNITROSAMINE; MESSENGER RNA; SOPHOCARPINE; TLR4 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL PROLIFERATION; CELL SIGNALING ASSAY; CONTROLLED STUDY; GENE EXPRESSION; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STELLATE CELL; WESTERN BLOTTING; ANIMAL; BILE DUCT; CELL CULTURE; CHEMISTRY; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; SURGERY;

ALKALOIDS; ANIMALS; BILE DUCTS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; COLORING AGENTS; DIMETHYLNITROSAMINE; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84894247483     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i7.1822     Document Type: Article

References (50)

1. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250 [PMID: 10644669 DOI: 10.1074/jbc.275.4.2247]
2. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003; 124: 147-159 [PMID: 12512039 DOI: 10.1053/ gast.2003.50012]
3. Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct 2003; 28: 105-112 [PMID: 12808230 DOI: 10.1247/ csf.28.105]
4. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210 [PMID: 18161745 DOI: 10.1002/ path.2277]
5. Nolan JP. The role of endotoxin in liver injury. Gastroenterology 1975; 69: 1346-1356 [PMID: 1104401]
6. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218 [PMID: 15690074 DOI: 10.1172/JCI24282]
7. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13: 1324-1332 [PMID: 17952090. DOI: 10.1038/nm1663]
8. Brun P, Castagliuolo I, Pinzani M, Palù G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2005; 289: G571-G578 [PMID: 15860640 DOI: 10.1152/ajpgi.00537.2004]
9. Lin Z, Huang CF, Liu XS, Jiang J. In vitro anti-tumour activities of quinolizidine alkaloids derived from Sophora flavescens Ait. Basic Clin Pharmacol Toxicol 2011; 108: 304-309 [PMID: 21159130 DOI: 10.1111/j.1742-7843.2010.00653.x]
10. Gao Y, Li G, Li C, Zhu X, Li M, Fu C, Li B. Anti-nociceptive and anti-inflammatory activity of sophocarpine. J Ethnopharmacol 2009; 125: 324-329 [PMID: 19607897 DOI: 10.1016/ j.jep.2009.06.036]
11. Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J. Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol 2008; 8: 1767-1772 [PMID: 18775799 DOI: 10.1016/j.intimp.2008.08.008]
12. Song CY, Zeng X, Chen SW, Hu PF, Zheng ZW, Ning BF, Shi J, Xie WF, Chen YX. Sophocarpine alleviates non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 2011; 26: 765-774 [PMID: 21054517 DOI: 10.1111/j.1440-1746.2010.06561.x]
13. Zhong W, Shen WF, Ning BF, Hu PF, Lin Y, Yue HY, Yin C, Hou JL, Chen YX, Zhang JP, Zhang X, Xie WF. Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats. Hepatology 2009; 50: 1524-1536 [PMID: 19787807 DOI: 10.1002/hep.23189]
14. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, Caporale R, Laffi G, Pinzani M, Gentilini P. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466-478 [PMID: 10930382 DOI: 10.1053/gast.2000.9365]
15. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835 [PMID: 8502273 DOI: 10.1056/NEJM199306243282508]
16. Byl B, Roucloux I, Crusiaux A, Dupont E, Devière J. Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 1993; 104: 1492-1497 [PMID: 8482461]
17. Spirlì C, Nathanson MH, Fiorotto R, Duner E, Denson LA, Sanz JM, Di Virgilio F, Okolicsanyi L, Casagrande F, Strazzabosco M. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. Gastroenterology 2001; 121: 156-169 [PMID: 11438505 DOI: 10.1053/gast.2001.25516]
18. Albillos A, Muñoz L, Nieto M, Ubeda M, de-la-Hera A, Alvarez-Mon M. Systemic effects of TNF-alpha secreted by circulating monocytes and fatigue in cirrhosis. Hepatology 2006; 43: 1399; author reply 1399-1400 [PMID: 16729299 DOI: 10.1002/hep.21205]
19. Tiggelman AM, Boers W, Linthorst C, Sala M, Chamuleau RA. Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma. J Hepatol 1995; 23: 307-317 [PMID: 8550995]
20. Napoli J, Bishop GA, McCaughan GW. Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology 1994; 107: 789-798 [PMID: 8076766. DOI: 10.1016/0016-5085(94)90128-7]
21. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-274 [PMID: 1612333]
22. Koff RS. Transforming growth factors in human chronic hepatitis and cirrhosis: correlations with fibrogenesis and hepatic regeneration. Gastroenterology 1991; 101: 1445-1446 [PMID: 1936817]
23. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991; 139: 1221-1229 [PMID: 1750499]
24. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002; 36: 200-209 [PMID: 11830331. DOI: 10.1016/S0168-8278(01)00260-4]
25. De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005; 174: 2037-2045 [PMID: 15699133]
26. Lichtman SN, Wang J, Lemasters JJ. LPS receptor CD14 participates in release of TNF-alpha in RAW 264.7 and peritoneal cells but not in kupffer cells. Am J Physiol 1998; 275: G39-G46 [PMID: 9655682]
27. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168: 554-561 [PMID: 11777946]
28. Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut 2009; 58: 704-720 [PMID: 19359436. DOI: 10.1136/gut.2008.156307]
29. Nolan JP, Leibowitz AI. Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin b--an antiendotoxin. Gastroenterology 1978; 75: 445-449 [PMID: 210083]
30. Grinko I, Geerts A, Wisse E. Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia. J Hepatol 1995; 23: 449-458 [PMID: 8655963 DOI: 10.1016/0168-8278(95)80204-5]
31. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195 [PMID: 12110890 DOI: 10.1038/nature00858]
32. Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, Chu CJ, Lu RH, Lee SD. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol 1997; 32: 942-946 [PMID: 9299675 DOI: 10.3109/00365529709 011206]
33. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, Huang CC, Wang SS, Lo KJ. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995; 22: 165-172 [PMID: 7790704 DOI: 10.1016/0168-8278(95)80424-2]
34. Aoyama T, Paik YH, Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract 2010; 2010: pii:192543 [PMID: 20706677 DOI: 10.1155/2010/192543]
35. Scott MJ, Billiar TR. Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J Biol Chem 2008; 283: 29433-29446 [PMID: 18701460 DOI: 10.1074/jbc. M803905200]
36. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003; 37: 1043-1055 [PMID: 12717385 DOI: 10.1053/jhep.2003.50182]
37. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48: 322-335 [PMID: 18506843 DOI: 10.1002/hep.22306]
38. Gäbele E, Mühlbauer M, Dorn C, Weiss TS, Froh M, Schnabl B, Wiest R, Schölmerich J, Obermeier F, Hellerbrand C. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem Biophys Res Commun 2008; 376: 271-276 [PMID: 18760996. DOI: 10.1016/j.bbrc.2008.08.096]
39. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511 [PMID: 15229469 DOI: 10.1038/ nri1391]
40. Davis BH, Chen A, Beno DW. Raf and mitogen-activated protein kinase regulate stellate cell collagen gene expression. J Biol Chem 1996; 271: 11039-11042 [PMID: 8626642 DOI: 10.1074/jbc.271.19.11039]
41. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, Efsen E, Laffi G, Gentilini P. Extracellular signalregulated kinase activation differentially regulates plateletderived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology 1999; 30: 951-958 [PMID: 10498647 DOI: 10.1002/hep.510300406]
42. Svegliati-Baroni G, Ridolfi F, Caradonna Z, Alvaro D, Marzioni M, Saccomanno S, Candelaresi C, Trozzi L, Macarri G, Benedetti A, Folli F. Regulation of ERK/JNK/ p70S6K in two rat models of liver injury and fibrosis. J Hepatol 2003; 39: 528-537 [PMID: 12971962 DOI: 10.1016/ S0168-8278(03)00291-5]
43. Kluwe J, Pradere JP, Gwak GY, Mencin A, De Minicis S, Osterreicher CH, Colmenero J, Bataller R, Schwabe RF. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. Gastroenterology 2010; 138: 347-359 [PMID: 19782079 DOI: 10.1053/gastro.2009.09.015]
44. Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 2010; 53: 132-144 [PMID: 20447716. DOI: 10.1016/j.jhep.2010.02.027]
45. Liu Y, Wang Z, Kwong SQ, Lui EL, Friedman SL, Li FR, Lam RW, Zhang GC, Zhang H, Ye T. Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J Hepatol 2011; 55: 612-625 [PMID: 21251937 DOI: 10.1016/ j.jhep.2010.11.035]
46. Iacobini C, Menini S, Ricci C, Blasetti Fantauzzi C, Scipioni A, Salvi L, Cordone S, Delucchi F, Serino M, Federici M, Pricci F, Pugliese G. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. J Hepatol 2011; 54: 975-983 [PMID: 21145823 DOI: 10.1016/j.jhep.2010.09.020]
47. Bellafante E, Murzilli S, Salvatore L, Latorre D, Villani G, Moschetta A. Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis. Hepatology 2013; 57: 1343-1356 [PMID: 23299802. DOI: 10.1002/hep.26222]
48. Robert K, Nehmé J, Bourdon E, Pivert G, Friguet B, Delcayre C, Delabar JM, Janel N. Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 2005; 128: 1405-1415 [PMID: 15887121 DOI: 10.1053/j.gastro.2005.02.034]
49. Suliman HB, Welty-Wolf KE, Carraway MS, Schwartz DA, Hollingsworth JW, Piantadosi CA. Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J 2005; 19: 1531-1533 [PMID: 15994412 DOI: 10.1096/fj.04-3500]
50. Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S. Innate immunity in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2011; 300: G516-G525 [PMID: 21252049 DOI: 10.1152/ajpgi.00537.2010]